Clinical Trial: Trial of rPA-102 Vaccine in Healthy Adult Volunteers
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 2 Multi-Center, Randomized Dose-Finding Trial of rPA-102 Vaccine in Healthy Adult Volunteers
Brief Summary: The purpose of this study is to assess the safety and immunogenicity of rPA102 vaccine given intramuscularly at 0 and 4 weeks over 2 dose ranges and 4 adjuvant levels.
Detailed Summary:
Sponsor: VaxGen
Current Primary Outcome: Safety and immune response to vaccine.
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: VaxGen
Dates:
Date Received: January 5, 2005
Date Started: April 2004
Date Completion: July 2005
Last Updated: January 10, 2006
Last Verified: January 2006